July 24 - Aug. 4, 2017

July 28- Aug. 4, 2017

Cources@CRG: Tissue Engineering Course: From STEM Cells to Organiods 

Selected participants will get an overview of the background and current methods for the generation and characterization of pluripotent stem cells, primordial germ cells, organoids and their genetic manipulation by CRISPR/Cas9 technology.

Location: Barcelona, Spain 

Registration: http://www.crg.eu/en/event/coursecrg-tissue-engineering-course-stem-cells-organoids

Aug. 17, 2017

JAX Webinar: Achieving Reproducible Mouse Studies 

Success in the drug development pipeline depends on success in basic and preclinical research. Join us to learn about unique experimental design considerations for mouse-based research. We will discuss topics critically important to the reproducibility of your mouse studies:(1) Suitability of phenotypic readout (2) Appropriate model and control selection (3) Sample size planning.

More information: https://www.jax.org/education-and-learning/education-calendar/webinars/2017/082017/reproducible-mouse-studies-aug-17

Aug. 23, 2017

The purpose of this Funding Opportunity Announcement (FOA) is to invite applications for the Centers for AIDS Research (CFAR) program to provide administrative and shared research support to enhance HIV/AIDS research. CFARs provide core facilities, expertise, resources, and services not readily obtained otherwise through more traditional funding mechanisms. The program emphasizes interdisciplinary collaboration across all areas of HIV/AIDS research.

More information:  https://www.niddk.nih.gov/research-funding/current-opportunities/par-17-237

Aug. 22, 2017 

Letter of Intent Due Date: NIH Director's Early Independence Awards (DP5)

Part of the High-Risk, High-Reward Research program, the award supports outstanding junior scientists with the intellect, scientific creativity, drive, and maturity to flourish independently by bypassing the traditional post-doctoral training period. • Must receive doctoral degree or complete medical residency between June 1, 2016 and September 30, 2018 • Must be in non-independent research position at time of application • Requires significant institutional support • Single PI only • Preliminary data not required • $250,000 direct costs per year for up to 5 years • Minimum of 80% research effort in first 2 years • 3-5 Letters of Reference required

More information:https://commonfund.nih.gov/earlyindependence

Aug. 25, 2017 

Funding Opportunity Application Due Date: Lasker Clinical Research Scholars Program (Si2/R00)

The program offers the opportunity for a unique bridge between the NIH intramural and extramural research communities and contains two phases. In the first phase, Lasker scholars will receive appointments for up to 5-7 years as tenure-track investigators within the NIH Intramural Research Program with independent research budgets. In the second phase, successful scholars will receive up to 3 years of NIH support for their research at an extramural research facility; or, the scholar can be considered to remain as an investigator within the intramural program.

More information: https://grants.nih.gov/grants/guide/pa-files/PAR-17-254.html

Aug. 28, 2017 

The NIH Common Fund Metabolomics Program Funding Opportunities Pre-Application Webinar 

Topic: Metabolomics Stage 2 Pre-application Information Date: August 28, 2017 Time: 12:00 pm Eastern Daylight Time Registration is required.

More information: https://commonfund.nih.gov/metabolomics/webinars

Aug. 28, 2017 

Funding Opportunity Application Due Date: Collaborative Computational Tools for the Human Cell Atlas

The Chan Zuckerberg Initiative invites applications to develop computational tools, algorithms, visualizations, and benchmark datasets in support of the Human Cell Atlas. Participants in this project will collaborate with each other and with Chan Zuckerberg Initiative scientists and engineers to accelerate progress, facilitate communication, and maximize open dissemination of the resulting tools. The goal of the International Human Cell Atlas project is to create a shared, open reference atlas of all cells in the healthy human body as a resource for studies of health and disease. This endeavor will generate molecular and imaging data across a range of modalities and spatial scales, requiring new probabilistic and integrative approaches for analysis and interpretation, systematic comparison of methods on benchmark datasets, and mechanisms for disseminating these methods to a wide community. The Chan Zuckerberg Initiative seeks applications for the development of computational tools, algorithms, visualizations, and benchmark datasets in support of this endeavor. This program welcomes applicants who are new to the Human Cell Atlas — no prior work in this area is required. In a new approach to open, collaborative development, researchers on projects funded by these grants shall work together and share progress with each other to evaluate the strengths of different approaches. To maximize the impact and visibility of this work, members of the Chan Zuckerberg Initiative science and engineering teams will work with successful grant recipients to help enhance and package their tools, and link them to the Human Cell Atlas Data Coordination Platform (DCP), if appropriate and desired.

More information: https://chanzuckerberg.com/initiatives/rfa

Aug. 31, 2017 

Funding Opportunity Application Due Date: University of Chicago Digestive Diseases Research Core Center Pilot and Feasibility Program

The overarching theme of the DDRCC is research in Digestive Health and Disease, including inflammatory bowel diseases (IBD) and related areas of intestinal inflammation, immunology, the gut microbiome, metabolism, and epithelial biology/cancer of the GI tract. Pilot and Feasibility applications focused on these “mission” areas will receive higher priority. Broad aspects of basic and translational/clinical research related to enteric microbiology, inflammation, and immunology of the digestive tract and pathogenesis, genetics, pathophysiology, and bench-to-bedside aspects of inflammatory bowel diseases will be given higher priority. In addition, proposals focused on the examination of growth and differentiation, cancer biology, intestinal epithelial biology and pathobiology of the gastrointestinal tract (including the luminal GI tract, liver, pancreas, biliary system, etc.), as well as basic or clinical research in the areas of nutrition, metabolism, and digestive diseases are appropriate topics for Pilot & Feasibility studies.

More information: http://www.uchicagoddrcc.org/about-us